AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVO RESOURCES CORP-CDI

0.115

-0.005-4.17%

Volume:141.54K

Turnover:16.49K

Market Cap:40.78M

PE:-1.55

High:0.120

Open:0.120

Low:0.115

Close:0.120

Loading ...

Overview Company News Filings

Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th

Catalent's Proposed Acquisition by Novo Holdings Wins European Commission Nod

MT Newswires Live

European Equities Traded in the US as American Depositary Tread Water in Friday Trading

MT Newswires Live

Novo Resources Secures AU$11.5 Million from Partial Sale of San Cristobal Shares

MT Newswires Live

Sector Update: Health Care Stocks Decline Thursday Afternoon

MT Newswires Live

Novo Nordisk to Cut Prices of Insulin Products by Over 70%

MT Newswires Live

Novo Resources strengthens balance sheet with $11.5m San Cristobal Mining sale

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires Live

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Powell Speech

MT Newswires Live

Eli Lilly's Zepbound Beats Novo Nordisk's Wegovy In Head-To-Head Weight-Loss Trial

Eli Lilly's Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial

MT Newswires Live

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200 Million

MT Newswires Live

Sector Update: Health Care Stocks Decline Premarket Tuesday

MT Newswires Live

Market Chatter: Novo Nordisk's India Executives Push for Wegovy Launch in 2025

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live

Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight

MT Newswires Live

Sector Update: Health Care Stocks Advance Tuesday Afternoon

MT Newswires Live

Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

European Equities Close Lower in Tuesday Trading

MT Newswires Live

Top Stock Movers Now: Amgen, Best Buy, JM Smucker, and More

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVO.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","market":"AU","secType":"STK","nameCN":"NOVO RESOURCES CORP-CDI","latestPrice":0.115,"timestamp":1745820720000,"preClose":0.12,"halted":0,"volume":141542,"delay":0,"nameEN":"NOVO RESOURCES CORP-CDI","floatShares":314709406,"shares":354630279,"eps":-0.0739604207497935,"marketStatus":"Closed","change":-0.005,"latestTime":"04-28 16:12:00 AEST","open":0.12,"high":0.12,"low":0.115,"amount":16485,"amplitude":0.041667,"askPrice":0.12,"askSize":67230,"bidPrice":0.11,"bidSize":9050,"shortable":3,"etf":0,"ttmEps":-0.0739604207497935,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1694268000000,"exchange":"ASX","adjPreClose":0.12,"openAndCloseTimeList":[[1745798400000,1745820000000]],"volumeRatio":2.462808,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","floatShares":314709406,"roa":"-13.14%","roe":"-30.09%","lyrEps":-0.07396,"volumeRatio":2.462808,"shares":354630279,"dividePrice":0,"high":0.12,"amplitude":0.041667,"preClose":0.12,"low":0.115,"week52Low":0.081,"pbRate":"0.52","psRate":"14.49","week52High":0.165,"institutionHeld":0,"latestPrice":0.115,"committee":-0.762716,"eps":-0.0739604207497935,"divideRate":0,"volume":141542,"delay":0,"ttmEps":-0.0739604207497935,"open":0.12,"prevYearClose":0.094,"prevWeekClose":0.12,"prevMonthClose":0.098,"prevQuarterClose":0.098,"fiveDayClose":0.11,"twentyDayClose":0.095,"sixtyDayClose":0.095},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490170651","title":"Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th","url":"https://stock-news.laohu8.com/highlight/detail?id=2490170651","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490170651?lang=en_us&edition=fundamental","pubTime":"2024-12-10 01:51","pubTimestamp":1733766660,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec. 09, 2024  -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Precious Metals & Critical Materials Virtual Investor Conference to be held December 10th and 11th. Individual investors, institutional investors, advisors, and analysts are invited to attend.It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.“OTC Markets is delighted to host the Precious Metals & Critical Materials Virtual Investor Conference with a variety of OTCQX and OTCQB-traded companies presenting,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “We appreciate the collaboration of our participating companies and look forward to these strategic discussions.”","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/precious-metals-critical-materials-virtual-175100190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["VIC.AU","OCGSF","BK7095","BK4144","GIGGF","BK4544","BK4168","BK4120","RIOFF","ESGLF","LUCMF","BK4581","AMRRY","BK4561","ET","NVO.AU","ARR.AU","MYRUF","BK4188","MTM.AU","ARKG","BK4585","FRSPF","BK4017","LCGMF","BK4210","BK4590","AAGFF","YGTFF","BK4588","BK4015","ATCUF","SLVTF","NSRPF"],"gpt_icon":0},{"id":"2489252461","title":"Catalent's Proposed Acquisition by Novo Holdings Wins European Commission Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2489252461","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489252461?lang=en_us&edition=fundamental","pubTime":"2024-12-07 02:33","pubTimestamp":1733510004,"startTime":"0","endTime":"0","summary":"Catalent's  proposed acquisition by Novo Nordisk's  parent Novo Holdings has been approved by the European Commission \"unconditionally,\" the Commission said Thursday.The Commission said it determined after an investigation that the transaction would not raise competition concerns in the European Economic Area.Catalent and Novo Holdings said Friday that the transaction is on track to close toward the end of the year.The all-cash deal, which values Catalent at $16.5 billion, could help boost production of Novo Nordisk's weight-loss drug Wegovy.Novo Nordisk's shares in the US added 2% in recent Friday trading.Price: 61.89, Change: -0.23, Percent Change: -0.37","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTLT","BK4532","BK4585","NVO.AU","LU0154236417.USD","BK4588","BK4599","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK7104","BK4530","LU1093756168.USD","BK4007"],"gpt_icon":1},{"id":"2489525285","title":"European Equities Traded in the US as American Depositary Tread Water in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2489525285","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489525285?lang=en_us&edition=fundamental","pubTime":"2024-12-07 00:03","pubTimestamp":1733500993,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were treading water late Friday morning, edging 0.055% higher to 1,351.69 on the S&P Europe Select ADR Index, which has gained 1.4% f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","E","BK4107","BK4585","SQNS","LU0084288595.USD","BK7104","AFG","BK4082","LU1093756168.USD","DBVT","DAVA.AU","IE00BZ1G4Q59.USD","BK4548","AMRN","LU1162221912.USD","BK4141","BK4551","LU1093756325.SGD","BNTX","LU0648005311.SGD","BK4134","BK4139","DAVA","BCYC","NVO.AU","OPRA","MTLS","BK4532","BK4546","LU0154236417.USD","BK4505","BK4599","NVO","LU0278409577.USD","BK4201","MREO","LU0162691827.USD","IE00BKVL7J92.USD","SHEL","LU0300736062.USD","LU0072461881.USD","BK4023","BP","BK4007","SLN","TRIB","BK4535","BK4568","EQNR"],"gpt_icon":1},{"id":"2489471531","title":"Novo Resources Secures AU$11.5 Million from Partial Sale of San Cristobal Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2489471531","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489471531?lang=en_us&edition=fundamental","pubTime":"2024-12-06 14:58","pubTimestamp":1733468315,"startTime":"0","endTime":"0","summary":"Novo Resources  received gross proceeds of AU$11.5 million through the sale of 38% of its shareholding in privately-held San Cristobal Mining, according to a Thursday filing with the Australian bourse.The transaction exceeds the internal fair value of the San Cristobal shares as recorded on Novo Resources' balance sheet as of Sep. 30.Following the sale, Novo estimates the remaining stake in San Cristobal to be valued at AU$19 million, the filing said.The funds from the sale will be directed toward advancing exploration activities in Western Australia and Victoria and repaying the first portion of AU$3 million of deferred consideration due to IMC Holdings by late December.Following the first payment, the outstanding balance to IMC Holdings will be AU$12.6 million due by 2026, with early repayment options. The Company also paid $90,000 in finders' fees.Novo's cash balance as of Dec.4 stands at AU$16.7 million.Novo Resources expects to incur capital gains tax of AU$1.4 million for the sal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","NVO.AU","XKO.AU","XAO.AU","XJO.AU"],"gpt_icon":1},{"id":"2489994254","title":"Sector Update: Health Care Stocks Decline Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2489994254","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489994254?lang=en_us&edition=fundamental","pubTime":"2024-12-06 02:58","pubTimestamp":1733425092,"startTime":"0","endTime":"0","summary":"Health care stocks fell Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each shedding 1%.The iShares Biotechnology ETF  was down 0.9%.In corporate news, Protara Therapeutics  shares surged 85% after the company said its investigational therapy TARA-002 showed a complete response rate of 72% at six months in a phase 2 trial involving people with non-muscle invasive bladder cancer.Novo Nordisk  said Thursday it plans to significantly reduce the list price paid by US customers for its Tresiba and Fiasp insulin products starting January 2026. Its shares eased 0.2%.Nano-X Imaging  shares popped 2.4% after the company said it received 510 clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK4532","XLV","IE00BKVL7J92.USD","NVO.AU","BK4585","BK4599","NVO","BK4581","IE00BZ1G4Q59.USD","BK4139","BK4588","IBB","BK4007","LU0154236417.USD","NNOX","TARA","BK7104","BK4196","LU1093756168.USD","BK4082"],"gpt_icon":1},{"id":"2489449634","title":"Novo Nordisk to Cut Prices of Insulin Products by Over 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489449634","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489449634?lang=en_us&edition=fundamental","pubTime":"2024-12-06 02:28","pubTimestamp":1733423321,"startTime":"0","endTime":"0","summary":"Novo Nordisk  Thursday said it plans to significantly reduce the list price paid by US customers for its Tresiba and Fiasp insulin products starting January 2026.The price of vials and pre-filled injector pens of the company's fast-acting Fiasp insulin will drop 75%, matching the price of its Novolog insulin, while the price of various dispensers of its long-acting Tresiba insulin analog will fall by 72.2%, making it 20% lower than its unbranded equivalent, insulin degludec, the Danish drugmaker said.Novo Nordisk will cease production of its unbranded insulin biologicals by the end of 2025 and said it wanted to provide healthcare professionals, wholesalers and insurers with more than 12 months advance notice to ensure a smooth transition for patients.Price: 108.87, Change: -0.10, Percent Change: -0.09","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","NVO.AU","BK4588","BK7104","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","BK4532","LU0154236417.USD"],"gpt_icon":1},{"id":"2489179602","title":"Novo Resources strengthens balance sheet with $11.5m San Cristobal Mining sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2489179602","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489179602?lang=en_us&edition=fundamental","pubTime":"2024-12-05 09:21","pubTimestamp":1733361705,"startTime":"0","endTime":"0","summary":"Novo Resources  has bolstered its financial position with the sale of 38% of the company’s holding in San Cristobal Mining for gross proceeds of around $11.5 million.The sale leaves Novo with a strong balance sheet, including cash of $16.7 million and investments of approximately $44.6m.Novo’s remaining shareholding in San Cristobal has an estimated value of $19m.Acting chief executive officer Mike Spreadborough said the funds received from the sale will support Novo’s current exploration programs across Western Australia and Victoria and enable the company to focus on identifying additional exploration opportunities.The funds will also be used to repay the first portion of the deferred $3m consideration owed to IMC Holdings, due in late December 2024.The outstanding amount owing to IMC following this will be $12.6m, repayable by 2026 with early repayment options.Austroid Australia acquired the remaining 20% of the JV, along with Novo’s 100% interest in gold and silver rights for $850,","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Novo-Resources-ASX-NVO-San-Cristobal-Mining-divestment.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Novo-Resources-ASX-NVO-San-Cristobal-Mining-divestment.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/novo-resources-strengthens-balance-sheet-san-cristobal-mining-sale/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["NVO.AU","BK7104"],"gpt_icon":1},{"id":"2488191221","title":"Sector Update: Health Care Stocks Steady Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2488191221","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488191221?lang=en_us&edition=fundamental","pubTime":"2024-12-04 22:14","pubTimestamp":1733321690,"startTime":"0","endTime":"0","summary":"Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund  and the iShares Biotechnology ETF  were flat recently.Cross Country Healthcare  shares surged past 62% after the company and Aya Healthcare announced an agreement under which Aya will acquire Cross Country Healthcare for $18.61 per share in cash for roughly $615 million in transaction value.Heron Therapeutics  shares rose by over 72% after the company said it won a patent dispute over its Cinvanti injectable emulsion against Fresenius Kabi USA.Novavax  shares were up over 2% after the company said it has agreed to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk  for $200 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","NVO.AU","BK4007","BK4599","CCRN","BK4547","BK4139","NVO","IE00BKVL7J92.USD","BK7104","LU1093756168.USD","LU0154236417.USD","BK4196","BK4585","HRTX","BK4588","IE00BZ1G4Q59.USD","BK4581","XLV","NVAX","BK4568","IBB","LU1093756325.SGD"],"gpt_icon":1},{"id":"2488201193","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Powell Speech","url":"https://stock-news.laohu8.com/highlight/detail?id=2488201193","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488201193?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:14","pubTimestamp":1733318049,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.1% in Wednesday's premarket activity, ahead of a speech by US ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXI","US10Y.BOND","US12M.BOND","VHT.AU","EQR","US6M.BOND","US2Y.BOND","XLK","IYE","RTH","HRL.AU","SOXX","XRT","XSD","GLD","US3Y.BOND","IYJ","RTH.AU","SPY","USO","QQQ","HRL","XLI","VIS","US5Y.BOND","VDC","US30Y.BOND","VHT","PSTG","IYH","NVAX","FDN","NVO.AU","FAZ","SPY.AU",".SPX","EEM","IGM","FAS","US7Y.BOND","IVV","IBB","LUNR","IPK","IGV",".IXIC","CRGY"],"gpt_icon":1},{"id":"2488116756","title":"Eli Lilly's Zepbound Beats Novo Nordisk's Wegovy In Head-To-Head Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488116756","media":"Blockhead","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488116756?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:16","pubTimestamp":1733314588,"startTime":"0","endTime":"0","summary":"Eli Lilly said Wednesday that its obesity drug Zepbound spurred more weight loss than Novo Nordisk's Wegovy in a head-to-head clinical trial.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2024/09/Stock-EliLilly-building-04-shutt-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/09/Stock-EliLilly-building-04-shutt-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e266721f8746851af3f56ae2b1743ae8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/eli-lilly-zepbound-beats-novo-nordisk-wegovy-in-head-to-head-weight-loss-trial/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["IE00BFTCPJ56.SGD","BK4588","LU0096364046.USD","LU0122379950.USD","LU0820561818.USD","SG9999014898.SGD","IE0002141913.USD","LU0943347566.SGD","LU0256863811.USD","SGXZ57979304.SGD","LU0672654240.SGD","LU0238689110.USD","LLY","LU1623119135.USD","LU2491049909.HKD","SG9999017495.SGD","LU0640476718.USD","LU0471298777.SGD","LU0823416689.USD","LU0882574055.USD","NVO","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU1291159041.SGD","LU1868837136.USD","LU2361044949.HKD","SG9999015986.USD","LU0061475181.USD","NVO.AU","LU1917777945.USD","LU2264538146.SGD","LU2237443549.SGD","LU0882574139.USD","LU2106854487.HKD","LU1093756168.USD","SG9999014906.USD","LU0820561909.HKD","LU2360106947.USD","LU2491050071.SGD","LU1868836591.USD","LU0289739699.SGD","LU2491050154.USD","LU1983299246.USD","SG9999014914.USD","LU0154236417.USD","LU1804176565.USD","IE00BJT1NW94.SGD","BK4516","LU1814569148.SGD","LU1868837300.USD"],"gpt_icon":1},{"id":"2488162945","title":"Eli Lilly's Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488162945","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488162945?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:05","pubTimestamp":1733313941,"startTime":"0","endTime":"0","summary":"Eli Lilly  said Wednesday its Surmount-5 phase 3b clinical study showed that Zepbound provided a 47% \"greater relative weight loss\" in comparison to Novo Nordisk's  Wegovy.Zepbound, Eli Lilly's weight-loss drug, resulted in a \"superior\" weight reduction of 20.2% against Wegovy's 13.7%, the company added.Eli Lilly's stock rose 2.3% in recent Wednesday premarket activity, while Novo Nordisk's shares were little changed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e266721f8746851af3f56ae2b1743ae8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1868837136.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU0096364046.USD","LU0094547139.USD","NVO.AU","LU2491049909.HKD","BK4581","LU0471298694.HKD","SG9999015945.SGD","LU2491050071.SGD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU0672654240.SGD","LU0122379950.USD","SG9999001176.USD","LU1623119135.USD","BK4588","LU0203202063.USD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1988902786.USD","SGXZ99366536.SGD","LU0061475181.USD","LU0708995401.HKD","LU0256863811.USD","LLY","SG9999015978.USD","SGXZ81514606.USD","LU0466842654.USD","SG9999018865.SGD","LU0820561818.USD","BK4516","LU1093756168.USD","LU0097036916.USD","LU0820561909.HKD","IE00BK4W5L77.USD","LU0689472784.USD","SG9999017495.SGD","LU0456855351.SGD","IE00B1BXHZ80.USD","SGXZ31699556.SGD","LU0640476718.USD","LU1127390331.HKD","LU0882574055.USD","LU1280957306.USD","NVO","LU1035775433.USD","LU1069344957.HKD"],"gpt_icon":1},{"id":"2488154232","title":"Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2488154232","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488154232?lang=en_us&edition=fundamental","pubTime":"2024-12-04 17:11","pubTimestamp":1733303480,"startTime":"0","endTime":"0","summary":"Novavax  said Wednesday it has agreed to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk  for $200 million.The asset sale includes a 150,000-square-foot recombinant protein manufacturing facility with support buildings.The consideration for the deal consists of a $190 million cash payment, and a $10 million additional payment in 2025.The company also expects the deal to reduce its annual operating costs by about $80 million.The deal is anticipated to close by Dec. 30.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","NVO.AU","LU0154236417.USD","BK7104","BK4585","LU1093756325.SGD"],"gpt_icon":1},{"id":"2488943541","title":"Sector Update: Health Care Stocks Decline Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2488943541","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488943541?lang=en_us&edition=fundamental","pubTime":"2024-12-03 22:18","pubTimestamp":1733235484,"startTime":"0","endTime":"0","summary":"Health care stocks were declining premarket Tuesday, with The Health Care Select Sector SPDR Fund  slightly lower and the iShares Biotechnology ETF  down 0.2%.Coherus BioSciences  shares were up past 69% after the company said it has agreed to divest its biosimilar drug Udenyca, which is based on Amgen's  Neulasta, to Intas Pharmaceuticals for up to $558.4 million.HUTCHMED  stock was over 3% higher after the company and Innovent Biologics said the new drug application for the combination of ELUNATE and TYVYT has been granted conditional approval in China for the treatment of certain patients with advanced endometrial cancer.Novo Nordisk's  India-based executives have proposed moving up the launch of the weight-loss drug Wegovy in the country to 2025, instead of 2026 as planned, due to concerns about falling behind Eli Lilly's  Mounjaro, Reuters reported, citing two sources familiar with the matter. Novo Nordisk shares were over 2% higher premarket.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1291159041.SGD","BK4532","LU2237443895.HKD","LU0114720955.EUR","LLY","LU0471298777.SGD","LU1035775433.USD","LU1267930730.SGD","LU0109391861.USD","LU0058720904.USD","LU0096364046.USD","LU1023059063.AUD","LU2211815571.USD","LU2491050154.USD","LU1093756325.SGD","NVO","SG9999015978.USD","SG9999013999.USD","HCM","LU0289739699.SGD","CHRS","LU0943347566.SGD","LU2237443549.SGD","LU2242646821.SGD","BK4007","XLV","LU2491049909.HKD","SGXZ31699556.SGD","LU0256863811.USD","NVO.AU","AMGN","LU0354030438.USD","LU0640476718.USD","BK4535","LU2242652126.USD","SG9999014906.USD","SG9999015945.SGD","BK4531","LU0471298694.HKD","LU1366192091.USD","LU1983299246.USD","LU2237443622.USD","LU0868494617.USD","LU1064131342.USD","SG9999018865.SGD","IBB","LU2468319806.SGD","LU0094547139.USD","IE00B2B36J28.USD","BK4588"],"gpt_icon":1},{"id":"2488911834","title":"Market Chatter: Novo Nordisk's India Executives Push for Wegovy Launch in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2488911834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488911834?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:35","pubTimestamp":1733229317,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  India-based executives have proposed moving up the launch of the weight-loss drug Wegovy in the country to 2025, instead of 2026 as planned, due to concerns about falling behind Eli Lilly's  Mounjaro, Reuters reported Tuesday, citing two sources familiar with the matter.Eli Lilly plans to launch Mounjaro in India around the same time, according to the report.Novo Nordisk officials earlier said Wegovy might be launched in India in 2026 as soon as regulatory approvals are obtained and enough supply is assured. The company received regulatory approval in India for injectable semaglutide, the active ingredient in Wegovy, in late 2022, Reuters said.Novo Nordisk did not immediately respond to requests for comment from MT Newswires.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"08f768b06424a08465803ba6c2eecb42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","LU2063271972.USD","LU1868836757.USD","LU2360106947.USD","LU0006306889.USD","LU0061475181.USD","IE00BK4W5M84.HKD","BK4585","LU2361044949.HKD","IE00B4R5TH58.HKD","LU1061106388.HKD","IE00B2B36J28.USD","LU1623119135.USD","LU1814569148.SGD","LU0109391861.USD","LU1035775433.USD","LU1551013425.SGD","LU2461242641.AUD","LU0672654240.SGD","LU2602419157.SGD","BK4532","NVO.AU","LU0256863811.USD","SG9999001176.SGD","LU0354030438.USD","LU1366192091.USD","LU1988902786.USD","LU2089984988.USD","LU0466842654.USD","BK4533","LU0058720904.USD","LU0256863902.USD","LU1804176565.USD","LU1069344957.HKD","LU2237443382.USD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU1291159041.SGD","SG9999014880.SGD","LU0320765059.SGD","LU1712237335.SGD","LU2237443895.HKD","SG9999001176.USD","LU0289739699.SGD","SG9999018857.SGD","SGXZ57979304.SGD","LLY","IE00BJT1NW94.SGD","LU1868836591.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2488603261","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2488603261","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488603261?lang=en_us&edition=fundamental","pubTime":"2024-12-03 00:16","pubTimestamp":1733156163,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week trending lower late Monday morning, declining 0.37% to 1,326.63 on the S&P Europe Select ADR Index.From continent","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","TRIB","IE00BZ1G4Q59.USD","SLN","NVO","LU0162691827.USD","CUK","BK4201","LU1093756325.SGD","BK4554","LU0320765646.SGD","LU0154236417.USD","LU1829250122.USD","LU2237443978.SGD","BK4082","ERIC","NTZ","AFG","BK4505","BK4095","LU0072461881.USD","EVAX","BK4139","BP","BK4591","AKTX","BK4142","LU2237443382.USD","LU2129689431.USD","BK4515","LU2129689514.USD","BK4561","LU2237443622.USD","SQNS","BK4599","TCBP","BK4107","BK4141","LU1093756168.USD","LU2237443465.HKD","MREO","BK4023","OPRA","VRNA","GNFT","BK7104","LU2237443895.HKD","TTE","BK4007","BK4588"],"gpt_icon":1},{"id":"2486216238","title":"Novo Nordisk, KKR Joint Acquisition of Sylvan Gets EU Greenlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2486216238","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486216238?lang=en_us&edition=fundamental","pubTime":"2024-11-27 21:30","pubTimestamp":1732714214,"startTime":"0","endTime":"0","summary":"Novo Nordisk  and KKR's  joint acquisition of Sylvan International Biotechnology in China was cleared by the EU's antitrust review, the European Commission said Wednesday.The Commission said it found that the proposed transaction would not raise competition concerns as the joint venture would have \"negligible activities\" in the European Economic Zone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1668664300.SGD","IE00B64PRP62.GBP","LU1791807156.HKD","LU1935043023.USD","JYNT","BK4585","IE00B3QW5Z07.USD","LU1935043536.SGD","NVO.AU","BK4599","LU1093756325.SGD","BK4135","BK4588","LU1935042215.USD","BK4185","BK4007","IE00BKVL7J92.USD","LU1201861249.SGD","LU0980610538.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU0106831901.USD","BK7104","LU0648001328.SGD","LU1935042991.SGD","BK4156","LU0154236417.USD","BK4532","LU0314104364.USD","LU1935042488.USD","NVO","IE00BGHQF748.EUR","LU0130102774.USD","KKR"],"gpt_icon":0},{"id":"2486887020","title":"Sector Update: Health Care Stocks Advance Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2486887020","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486887020?lang=en_us&edition=fundamental","pubTime":"2024-11-27 02:49","pubTimestamp":1732646977,"startTime":"0","endTime":"0","summary":"Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund  up 0.2%.The iShares Biotechnology ETF  shed 0.3%.In corporate news, Arrowhead Pharmaceuticals  shares jumped past 16%. The company signed a global licensing and partnership agreement with Sarepta Therapeutics  to develop new therapies for genetic diseases of the muscle, central nervous system and lungs. Sarepta shares climbed more than 12%.Amgen  shares tumbled 7.7%. The company said a phase 2 trial showed that its investigational obesity drug MariTide demonstrated up to 20% average weight loss after a year in people living with obesity or overweight without type 2 diabetes. Mizuho said in a note that this efficacy is \"on the low end of expectations.\"The White House said Tuesday it's proposing a new rule to expand coverage of anti-obesity and diabetes medications made by companies such as Novo Nordisk  and Eli Lilly  for Americans with Medicare or Medicaid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0466842654.USD","LU1366192091.USD","LU1023059063.AUD","LU2023250504.SGD","LU1804176565.USD","LU0114720955.EUR","SG9999014880.SGD","LU2242646821.SGD","AMGN","BK4588","LU2324357040.USD","LU0672654240.SGD","NVO","SGXZ51526630.SGD","IBB","LU0079474960.USD","LU2491050154.USD","LU2491049909.HKD","LU0198837287.USD","IE00BK4W5M84.HKD","ARWR","LU0689472784.USD","SRPT","LU0109394709.USD","LU0354030438.USD","SGXZ99366536.SGD","LU1061106388.HKD","LU0256863902.USD","SGXZ57979304.SGD","IE0009355771.USD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU2237443895.HKD","LU1623119135.USD","LU0868494617.USD","SG9999015945.SGD","LU1712237335.SGD","LLY","NVO.AU","XLV","BK4534","BK4581","LU2602419157.SGD","IE00BJLML261.HKD","LU1571399168.USD","LU2361045086.USD","LU2237443549.SGD","LU0889565916.HKD","LU1988902786.USD","LU0354030511.USD"],"gpt_icon":1},{"id":"2486988411","title":"Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2486988411","media":"Investopedia","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486988411?lang=en_us&edition=fundamental","pubTime":"2024-11-27 01:44","pubTimestamp":1732643056,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in government-backed healthcare plans.The proposal recommended drugs like Ozempic and Mounjaro be covered under Medicare and Medicaid, making them more accessible to millions of new patients.The White House said the changes could also lower costs of the drugs.Eli Lilly  and Novo Nordisk  shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' popular weight-loss drugs in government-backed healthcare plans including Medicare and Medicaid.Current rules limit weight-loss drugs from being covered by the programs, and the proposed changes would classify drugs like Ozempic and Mounjaro as medications to treat obesity, with the reasoning that it can cause ailments like diabetes and heart disease, which are covered under the rules.New Classification Could Make Ozempic, Mounjaro More Accessible. Do you have a news ","market":"nz","thumbnail":"https://www.investopedia.com/thmb/copUnW6Af0hAaHyWPRHtnhCdr-0=/4759x3410/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2161043945-0728ca507d5e45859acdabeec55d352e.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/copUnW6Af0hAaHyWPRHtnhCdr-0=/4759x3410/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2161043945-0728ca507d5e45859acdabeec55d352e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/eli-lilly-novo-nordisk-stocks-gain-as-biden-moves-to-expand-coverage-of-weight-loss-drugs-8751926","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU1712237335.SGD","LU2237443465.HKD","LU1917777945.USD","BK7104","LU1868837136.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU2237438978.USD","LU1127390331.HKD","LU2346227817.USD","LU0238689110.USD","LU2264538146.SGD","BK4534","BK4007","LU2112291526.USD","LU0456855351.SGD","LU0094547139.USD","BK4533","LU0471298694.HKD","LU1814569148.SGD","LU2237443622.USD","LU1551013342.USD","NVO","LU0061475181.USD","LU0122379950.USD","LU0256863902.USD","LU2211815571.USD","LU0058720904.USD","SGXZ99366536.SGD","NVO.AU","LU1868837300.USD","LU2361045086.USD","LLY","LU2063271972.USD","LU2461242641.AUD","SG9999017495.SGD","LU2491050071.SGD","LU0289739699.SGD","SGXZ81514606.USD","IE00BZ1G4Q59.USD","CMS","LU1280957306.USD","LU0097036916.USD","IE0002141913.USD","LU0471298777.SGD","LU0882574055.USD","IE00B4R5TH58.HKD","LU2361044949.HKD","LU0820561909.HKD","LU0109391861.USD"],"gpt_icon":1},{"id":"2486155889","title":"European Equities Close Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2486155889","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486155889?lang=en_us&edition=fundamental","pubTime":"2024-11-27 01:21","pubTimestamp":1732641710,"startTime":"0","endTime":"0","summary":"European stock markets closed lower in Tuesday trading as the Stoxx Europe was down 0.57%, Germany's DAX dropped 0.56%, the FTSE in London fell 0.40%, France's CAC lost 0.87%, and the Swiss Market Ind","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","BK4585","LU0154236417.USD","BK4530","BK4588","LU1064927863.SGD","IE00BKVL7J92.USD","BK4561","BK4007","BK7104","BK4532","MT","BK4099","BK4006","NVO.AU","BK4599","CTLT","IE00BZ1G4Q59.USD","STLA","LU1093756168.USD","LU1093756325.SGD","NVO"],"gpt_icon":1},{"id":"2486884898","title":"Top Stock Movers Now: Amgen, Best Buy, JM Smucker, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2486884898","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486884898?lang=en_us&edition=fundamental","pubTime":"2024-11-27 01:03","pubTimestamp":1732640623,"startTime":"0","endTime":"0","summary":"U.S. equities were mixed at midday following comments from President-elect Trump about new tariffs on Chinese, Canadian, and Mexican imports.Results from a study of Amgen's experimental weight-loss treatment came in below expectations, sending shares sinking.J.M. Smucker raised its guidance on strong sales of its packaged and frozen foods.U.S. equities were mixed at midday as the markets weighed the potential impact of President-elect Donald Trump's plan to slap steeper tariffs on imports from China, and new ones on Canadian and Mexican products. The Dow Jones Industrial Average fell, while the S&P 500 and Nasdaq rose.Amgen  was the worst-performing stock in the Dow and S&P 500 after the biotech reported results from a study of its experimental weight-loss drug that came in below expectations.Shares of Best Buy  tumbled when the electronics retailer missed profit and revenue estimates and slashed its outlook, which it blamed on macroeconomic worries, customers waiting for deals, and th","market":"sg","thumbnail":"https://www.investopedia.com/thmb/1HUamBdeOZHPPjhN8ef6tXQ2jbE=/6000x4000/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1491081305-af5268c668254a858ffbdff7f23ff560.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/1HUamBdeOZHPPjhN8ef6tXQ2jbE=/6000x4000/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1491081305-af5268c668254a858ffbdff7f23ff560.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/top-stock-movers-now-amgen-best-buy-jm-smucker-and-more-8752087","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU1093756168.USD","WMT","LU2106854487.HKD","BK4516","LU0096364046.USD","LU2324357040.USD","AMGN","LU1868837300.USD","LU2430703178.SGD","LU2552382132.HKD","LU1267930490.SGD","BBY","LU2505996681.GBP","SJM","LU1366192091.USD","LU0211328371.USD","NVO","BK4212","LU1267930730.SGD","SG9999014914.USD","STZ","IE00BFTCPJ56.SGD","IE0002141913.USD","LU2125154778.USD","LU2461242641.AUD","LU1551013425.SGD","LU0238689110.USD","LU2491050154.USD","LU1585245621.USD","LU1066051225.USD","TGT","LLY","LU0868494617.USD","LU1988902786.USD","LU0385154629.USD","LU0198837287.USD","BK4169","LU0823411888.USD","LU0943347566.SGD","LU0094547139.USD","LU2063271972.USD","SGXZ99366536.SGD","LU2237443382.USD","LU0820561818.USD","SG9999014906.USD","BK4533","LU0006306889.USD","LU1868836914.USD","NVO.AU","LU0882574139.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":154,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO.AU\",market:\"AU\",,,undefined,":[]}}